- Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers
- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
- Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider
- Nordic Nanovector ASA - Resolution not to Proceed With a Repair Offering
Nordic Nanovector ASA (0R6Y:LSE) closed at 26.99, 35.36% above the 52 week low of 19.94 set on Nov 19, 2019.
19.94Nov 19 201952.89Jan 18 2019
Markit short selling activity
|Market cap||1.55bn NOK|
|EPS (TTM)||-7.23 |
Data delayed at least 20 minutes, as of Jan 17 2020 17:46 GMT.